- Home
- INVA vs CET Comparison
INVA vs CET Comparison
Compare INVA & CET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVA
- CET
- Stock Information
- Founded
- INVA 1996
- CET 1929
- Country
- INVA United States
- CET United States
- Employees
- INVA N/A
- CET N/A
- Industry
- INVA Biotechnology: Pharmaceutical Preparations
- CET Finance/Investors Services
- Sector
- INVA Health Care
- CET Finance
- Exchange
- INVA Nasdaq
- CET Nasdaq
- Market Cap
- INVA 1.2B
- CET 1.3B
- IPO Year
- INVA 2004
- CET N/A
- Fundamental
- Price
- INVA $18.23
- CET $46.23
- Analyst Decision
- INVA Buy
- CET
- Analyst Count
- INVA 1
- CET 0
- Target Price
- INVA N/A
- CET N/A
- AVG Volume (30 Days)
- INVA 684.8K
- CET 33.2K
- Earning Date
- INVA 11-06-2024
- CET 01-01-0001
- Dividend Yield
- INVA N/A
- CET 4.97%
- EPS Growth
- INVA 46.55
- CET 64.57
- EPS
- INVA 0.99
- CET 10.32
- Revenue
- INVA $352,745,000.00
- CET $23,374,777.00
- Revenue This Year
- INVA $16.20
- CET N/A
- Revenue Next Year
- INVA N/A
- CET N/A
- P/E Ratio
- INVA $18.62
- CET $4.52
- Revenue Growth
- INVA 21.46
- CET 41.71
- 52 Week Low
- INVA $14.33
- CET $36.89
- 52 Week High
- INVA $21.28
- CET $49.51
- Technical
- Relative Strength Index (RSI)
- INVA 34.59
- CET 39.05
- Support Level
- INVA $18.33
- CET $46.16
- Resistance Level
- INVA $18.69
- CET $47.52
- Average True Range (ATR)
- INVA 0.33
- CET 0.44
- MACD
- INVA -0.05
- CET -0.12
- Stochastic Oscillator
- INVA 13.61
- CET 3.36
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
About CET Central Securities Corporation
Central Securities Corp is a non-diversified closed-end management investment company. Its investment objective is long-term growth of capital. The company invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.